We are live on ! Find out more
ACIU icon

AC Immune
ACIU

22 hedge funds and large institutions have $143M invested in AC Immune in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

47% more funds holding

Funds holding: 15 → 22 (+7)

30% more capital invested

Capital invested by funds: $110M → $143M (+$33.2M)

2.52% more ownership

Funds ownership: 17.12% → 19.64% (+2.5%)

Holders
22
Holders Change
+7
Holders Change %
+46.67%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.2M
2
TCM
Tekla Capital Management
Massachusetts
+$1.54M
3
Morgan Stanley
Morgan Stanley
New York
+$687K
4
Renaissance Technologies
Renaissance Technologies
New York
+$132K
5
Barclays
Barclays
United Kingdom
+$120K

Top Sellers

Rank Fund Capital Flow
1
BAM
Belpointe Asset Management
Nevada
-$4.12K
2
Wells Fargo
Wells Fargo
California
-$212
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$70M +$14.2M +1,207,592 +28%
DFO
2
Duquesne Family Office
New York
$30.6M – – –
Temasek Holdings
3
Temasek Holdings
Singapore
$17.1M – – –
PC
4
PointState Capital
New York
$12.8M – – –
AG
5
Artal Group
Luxembourg
$6.4M – – –
TCM
6
Tekla Capital Management
Massachusetts
$2.2M +$1.54M +130,894 +320%
Citadel Advisors
7
Citadel Advisors
Florida
$993K – – –
Morgan Stanley
8
Morgan Stanley
New York
$747K +$687K +58,344 New
BAM
9
Belpointe Asset Management
Nevada
$650K -$4.12K -350 -0.7%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$564K +$14.3K +1,216 +3%
Janney Montgomery Scott
11
Janney Montgomery Scott
Pennsylvania
$206K +$47.9K +4,066 +34%
LBC
12
Lawrence B. Cohen
$167K – – –
Renaissance Technologies
13
Renaissance Technologies
New York
$143K +$132K +11,200 New
Barclays
14
Barclays
United Kingdom
$131K +$120K +10,200 New
Wells Fargo
15
Wells Fargo
California
$127K -$212 -18 -0.2%
CLOS
16
Compagnie Lombard Odier SCmA
Switzerland
$90K +$41.2K +3,500 +100%
Citigroup
17
Citigroup
New York
$71K – – –
AAMU
18
Amundi Asset Management US
Massachusetts
$45K +$41.2K +3,500 New
Deutsche Bank
19
Deutsche Bank
Germany
$44K – – –
EDRH
20
Edmond de Rothschild Holding
Switzerland
$20K +$18.6K +1,576 New
TRCT
21
Tower Research Capital (TRC)
New York
$7K +$6.46K +549 New
UBS Group
22
UBS Group
Switzerland
$1K +$730 +62 New

ACIU Hedge Fund Activity: Q4 2017 in Review

22 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2017, worth a combined $143M — up 30% from $110M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ACIU positions and 0 closed out — a net gain of 7 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $14.2M. The largest seller was Belpointe Asset Management, cutting an estimated $4.12K.

  • 22 institutional investors held AC Immune (ACIU) as of Q4 2017, up from 15 in Q3 2017.
  • Funds reported $143M of AC Immune stock for Q4 2017, up 30% quarter-over-quarter.
  • 7 funds opened new AC Immune positions in Q4 2017 and 0 closed out, a net change of +7 holders.
  • The largest AC Immune buyer in Q4 2017 was Fidelity Investments, an estimated $14.2M added.
  • The largest AC Immune seller in Q4 2017 was Belpointe Asset Management, an estimated $4.12K sold.

Based on aggregated 13F filings for Q4 2017.